(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OVAREVIVE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OVAREVIVE

ST13

US500000098043967

Class

5

Filing

98043967

Registration

7755625

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

08/22/2025

Trademark type

Word

Nice classes

5

Filing date

06/15/2023

Registration date

04/08/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/08/2025

Last transaction

08/22/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/01/2024

First use in commerce

03/01/2024

Drawing code

4

Owner type

16

Owner location

SAI YING PUN, HK

Examiner

WOOD, CAROLINE

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

REGENERATIVE BIO LIMITED
Regenerative Bio Holding (HK) Limited

Representatives

Yue (Robert) Xu Apex Attorneys at Law, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Ovarian anti-aging dietary supplement that delays ovarian agingdelays menopauseprolongs women's reproductive ageimproves fertility by providing antioxidant protection and microcirculation support for the ovariesas well as improving sex hormone balance; Baby food; Dietary supplements for animals; Dietary and nutritional supplements; Dietary and nutritional supplements for medical and pharmaceutical purposes; Enzyme dietary supplements; Folic acid dietary supplements; Medicinal herb extracts; Nutritional supplements; Nutritional supplements for medical and pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Protein dietary supplements; Vitamin supplements; Wheat germ dietary supplements; Yeast dietary supplements

Publications

History of USPTO decisions and trademark events.

25 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/21/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/08/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

04/08/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/15/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/15/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/22/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/21/2025

IUAF

USE AMENDMENT FILED

12/10/2024

EISU

TEAS STATEMENT OF USE RECEIVED

12/10/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

12/09/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/09/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/09/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/09/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/11/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/16/2024

PUBO

PUBLISHED FOR OPPOSITION

04/16/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/27/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/08/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

03/04/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/04/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

03/04/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/04/2024

DOCK

ASSIGNED TO EXAMINER

02/29/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/19/2023

NWAP

NEW APPLICATION ENTERED

06/19/2023

Continuous trademark protection

Get notified about every new filing that threatens OVAREVIVE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.